Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy
The DOI matches its Crossref record.
Abstract
BACKGROUND: The current study was performed to identify clinical features and independent predictors of survival in patients with bone metastases from hepatocellular carcinoma (HCC). METHODS: Patients (n = 205) with bone metastases from HCC received external beam radiotherapy (EBRT) between 1997 and 2007. Demographic variables, laboratory values, tumor characteristics, and treatment modalities were determined before EBRT. The total radiation dose ranged from 32 to 66 grays (Gy) (median, 50 Gy) and was focused on the involved bone. RESULTS: In 80 of 205 (39.0%) patients with bone metastasis from HCC, tumors were characterized by osteolytic, expansile soft‐tissue masses. Overall pain relief from EBRT occurred in 204 patients (99.5%). No consistent dose‐response relation was found for palliation of bone metastases with doses between 32 and 66 Gy (P = .068), but the retreatment rate was higher in patients with expansile soft tissue. On univariate analysis, shorter survival was associated with poorer Karnofsky performance status (KPS), higher γ‐glutamyltransferase and α‐fetoprotein levels, tumor size >5 cm, uncontrolled intrahepatic tumors, multifocal bone lesions, involvement of spinal vertebrae, extraosseous metastases, and a shorter disease‐free interval after an initial diagnosis of HCC. On multivariate analysis, pretreatment‐unfavorable predictors were associated with lower KPS, higher tumor markers, and uncontrolled intrahepatic tumor when KPS was considered. The median survival was 7.4 months. CONCLUSIONS: The results of the current study provide detailed information regarding clinical features, survival outcomes, and prognostic factors for HCC with bone metastases in a relatively large cohort of patients treated with EBRT. These prognostic factors will help in determining which dose and fraction are appropriate. Cancer 2009. © 2009 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Zhou, J., Sun, H.-C., Wang, Z., Cong, W.-M., Wang, J.-H., Zeng, M.-S., Yang, J.-M., Bie, P., Liu, L.-X., Wen, T.-F., et al. (2018) · Liver Cancer · doi:10.1159/000488035 · Cited by 649
Self-citationKorean Liver Cancer Association, K., & National Cancer Center, N. (2019) · Gut and Liver · doi:10.5009/gnl19024 · Cited by 391
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0294 · Cited by 343
Korean Liver Cancer Study Group (KLCSG), & National Cancer Center, K. (. (2015) · Korean Journal of Radiology · doi:10.3348/kjr.2015.16.3.465 · Cited by 201
“In HCC patients with symptomatic bone metastases, EBRT is reported to relieve pain in 75–99% of patients (366-370) as well as symptoms in patients with brain metastases from HCC (371).”
BackgroundN6-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis
Zheng, H., Cheng, Z.-J., Liang, B., Wang, Z.-G., Tao, Y.-P., Huang, S.-Y., Ni, J.-S., Li, H.-F., Yang, L., Yuan, S.-X., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.73570 · Cited by 33
Metadata
- Authors
- He, J., Zeng, Z., Tang, Z., Fan, J., Zhou, J., Zeng, M., Wang, J., Sun, J., Chen, B., Yang, P., & Pan, B.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2009-06-04
- Volume
- 115
- Issue
- 12
- Pages
- 2710-2720
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2010516650
- Cited by
- 136
- References
- 0
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. https://app.cochat.ai/papers/10.1002/cncr.24300
- The paper
- He, J., Zeng, Z., Tang, Z., Fan, J., Zhou, J., Zeng, M., Wang, J., Sun, J., Chen, B., Yang, P., & Pan, B. (2009). Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer. https://doi.org/10.1002/cncr.24300
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.